Retinal protective effects of topically administered agmatine on ischemic ocular injury caused by transient occlusion of the ophthalmic artery

Brazilian Journal of Medical and Biological Research

Volumn 45, Issue 3, 2012, Pages 212-215

  Hong, S ^a   Hara, H ^b   Shimazawa, M ^b   Hyakkoku, K ^b   Kim, C Y ^a   Seong, G J ^a  

^a Yonsei University College of Medicine   (South Korea)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Agmatine; Apoptosis; Ischemia; Neuroprotection; Retina

Indexed keywords

AGMATINE; EYE DROPS; HYALURONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENUCLEATION; EYE PROTECTION; EYEBALL; ISCHEMIC OCULAR INJURY; MALE; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OPHTHALMIC ARTERY; REPERFUSION; RETINA CELL; RETINA INJURY; RETINA ISCHEMIA; TREATMENT DURATION;

MUS;

EID: 84863390680     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2012007500020     Document Type: Article

References (20)

1. Reis DJ, Regunathan S. Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci 2000; 21: 187-193.
2. Halaris A, Plietz J. Agmatine: metabolic pathway and spectrum of activity in brain. CNS Drugs 2007; 21: 885-900.
3. Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994; 263: 966-969.
4. Gilad GM, Salame K, Rabey JM, Gilad VH. Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci 1996; 58: L-6.
5. Gilad GM, Gilad VH. Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats. Neurosci Lett 2000; 296: 97-100.
6. Kim JH, Yenari MA, Giffard RG, Cho SW, Park KA, Lee JE. Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury. Exp Neurol 2004; 189: 122-130.
7. Hong S, Lee JE, Kim CY, Seong GJ. Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line. BMC Neurosci 2007; 8: 81.
8. Hong S, Kim CY, Lee WS, Shim J, Yeom HY, Seong GJ. Ocular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat model. Exp Eye Res 2010; 90: 97-103.
9. Cheung W, Guo L, Cordeiro MF. Neuroprotection in glaucoma: drug-based approaches. Optom Vis Sci 2008; 85: 406-416.
10. Hara H, Huang PL, Panahian N, Fishman MC, Moskowitz MA. Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J Cereb Blood Flow Metab 1996; 16: 605-611.
11. Hyakkoku K, Hamanaka J, Tsuruma K, Shimazawa M, Hara H. Proteomic approach with LCMS-IT-TOF identified an increase of Rab33B after transient focal cerebral ischemia in mice. Exp Transl Stroke Med 2010; 2: 20.
12. Steele EC Jr, Guo Q, Namura S. Filamentous middle cerebral artery occlusion causes ischemic damage to the retina in mice. Stroke 2008; 39: 2099-2104.
13. Ju WK, Lindsey JD, Angert M, Patel A, Weinreb RN. Glutamate receptor activation triggers OPA1 release and induces apoptotic cell death in ischemic rat retina. Mol Vis 2008; 14: 2629-2638.
14. Russo R, Cavaliere F, Berliocchi L, Nucci C, Gliozzi M, Mazzei C, et al. Modulation of pro-survival and deathassociated pathways under retinal ischemia/reperfusion: effects of NMDA receptor blockade. J Neurochem 2008; 107: 1347-1357.
15. Sakamoto K, Ohki K, Saito M, Nakahara T, Ishii K. Histological protection by donepezil against neurodegeneration induced by ischemia-reperfusion in the rat retina. J Pharmacol Sci 2010; 112: 327-335.
16. Takei K, Sato T, Nonoyama T, Miyauchi T, Goto K, Hommura S. A new model of transient complete obstruction of retinal vessels induced by endothelin-1 injection into the posterior vitreous body in rabbits. Graefes Arch Clin Exp Ophthalmol 1993; 231: 476-481.
17. Brooks DE, Kallberg ME, Cannon RL, Komaromy AM, Ollivier FJ, Malakhova OE, et al. Functional and structural analysis of the visual system in the rhesus monkey model of optic nerve head ischemia. Invest Ophthalmol Vis Sci 2004; 45: 1830-1840.
18. Masuzawa K, Jesmin S, Maeda S, Kaji Y, Oshika T, Zaedi S, et al. A model of retinal ischemia-reperfusion injury in rats by subconjunctival injection of endothelin-1. Exp Biol Med 2006; 231: 1085-1089.
19. Iizuka Y, Hong S, Kim CY, Kim SK, Seong GJ. Agmatine pretreatment protects retinal ganglion cells (RGC-5 cell line) from oxidative stress in vitro. Biocell 2008; 32: 245-250.
20. Iizuka Y, Hong S, Kim CY, Yang WI, Lee JE, Seong GJ. Protective mechanism of agmatine pretreatment on RGC-5 cells injured by oxidative stress. Braz J Med Biol Res 2010; 43: 356-358.